1、Guide for Authors Types of PapersCancer Letters is an international journal that consider full length articles and mini reviews in the broad area of basic and translational oncology. Additionally, special issues highlight topical areas in cancer research. Areas of interest to the broad readership of
2、 Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer me
3、dicine. All original papers submitted to Cancer Letters will be evaluated by the Journals Editors and should be between 3000 and 3500 words. The Editorial Office has adopted a rating system, in order to establish which manuscripts will be sent out for peer review. The rating system allows the Editor
4、 to assess the manuscript in terms of the following criteria: * Presentation* Style and structure* Quality of English language* Whether the topic being covered is within the aims and scope of the journal* The manuscripts scientific novelty together with how it compares to other manuscripts submitted
5、 on similar topics. Those manuscripts which are judged as being eligible for consideration by the Editors will be subject to peer review. Page chargesThis journal has no page charges. Ethics in publishingFor information on Ethics in publishing and Ethical guidelines for journal publication seeand Et
6、hics and ProceduresThe editors and publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal code of conduct, these fundamental principles with respect to the authors paper are that the paper should:
7、* be the authors own original work, which has not been previously published elsewhere* reflect the authors own research and analysis and do so in a truthful and complete manner,* properly credit the meaningful contributions of co-authors and co-researchers,* not be submitted to more than one journal
8、 for consideration (ensuring it is not under redundant simultaneous peer review), and* be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent,
9、 research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a code that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the eve
10、nt of questions concerning author conduct. Relevant conflicts of interest should be disclosed (see Studies involving experiments with animals must state that their care was in accordance with institution guidelines. Conflict of interestAll authors must disclose any financial and personal relationshi
11、ps with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are
12、 no conflicts of interest then please state this: Conflicts of interest: none. See also Further information and an example of a Conflict of Interest form can be found at: Submission of ManuscriptsManuscripts should be submitted online atand the instructions on the site should be closely followed. Au
13、thors may submit manuscripts and track their progress through to final decision. Authors unable to submit online should contact the Editorial Office: Cancer Letters Editorial OfficeElsevier LtdThe BoulevardLangford LaneOxford OX5 1GBU.K.Tel : +44 (0)1865 843203Fax : +44 (0)1865 843992Email :cancerle
14、tters Submission of an article to Cancer Letters implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved
15、by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or any other language, without the written consent of the Publisher. Manuscripts should be submitted in Engli
16、sh. Authors full names, academic or professional affiliations, and addresses should be included on the first page. All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or the acquisition of data, or analysis and interpretation of
17、 data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted. The name, postal address, email address, phone and FAX numbers of the corresponding author should be provided. Authors should supply the names and email ad
18、dresses of 3 to 5 potential reviewers for their manuscript. To provide an international perspective, no more than 2 potential reviewers should be from the same country. Please do not suggest reviewers from your own institution, previous or current collaborators or Editorial Board members. Without re
19、viewer suggestions, processing of the manuscript may be delayed. Please do not contact any reviewers that you have suggested. Online submission guidelines can be followed at Via this website you will be guided stepwise through the creation and uploading of the various files. The system automatically
20、 converts source files into a single Adobe Acrobat PDF version of the article, which is used in the peer review process. Please note that although manuscript source files are converted to PDF at submission for the review process, these source files are needed for further processing after acceptance.
21、 All correspondence, including notification of the Editors decision and requests for revision, takes place by email and via the authors homepage, removing the need for a hard-copy paper trail. Submission declaration and verificationSubmission of an article implies that the work described has not bee
22、n published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible
23、authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the origina
24、lity detection service CrossCheck CopyrightThis journal offers authors a choice in publishing their research: Open access and Subscription. For subscription articlesUpon acceptance of an article, authors will be asked to complete a Journal Publishing Agreement (for more information on this and copyr
25、ight, see An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a Journal Publishing Agreement form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for inte
26、rnal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult If excerpts from other copyrighted works are included, the author(s) must
27、 obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult For open access articlesUpon acceptance of an article, authors will be asked to complete an Exclusive License Agreement (for m
28、ore information see Permitted reuse of open access articles is determined by the authors choice of user license (see Retained author rightsAs an author you (or your employer or institution) retain certain rights. For more information on author rights for:Subscription articles please seeOpen access a
29、rticles please see Role of the funding sourceYou are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of d
30、ata; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Funding body agreements and policiesElsevier has established agreements and developed policies to allow authors whose articles ap
31、pear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit US National Institutes of Health (NIH) voluntary posting (Public Access) policyElsevi
32、er facilitates author response to the NIH voluntary posting request (referred to as the NOH Public Access Policy; seehttp:/www.nih.gov/about/publicaccess/index.htm) by posting the peer-reviewed authors manuscript directly to PubMedCentral on request from the author, 12 months after formal publicatio
33、n. Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest) that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to facilitate processing. Upon such confirm
34、ation, Elsevier will submit to PubMedCentral on your behalf a version of your manuscripts that will include peer-review comments, for posting 12 months after formal publication. This will ensure that you have responded fully to the NIH request policy. There will be no need for you to post your manus
35、cript directly with PubMedCentral, and any such posting is prohibited. Open accessThis journal offers authors a choice in publishing their research: Open access Articles are freely available to both subscribers and the wider public with permitted reuse An open access publication fee is payable by au
36、thors or their research funderSubscription Articles are made available to subscribers as well as developing countries and patient groups through our access programs ( No open access publication fee All articles published open access will be immediately and permanently free for everyone to read and d
37、ownload. Permitted reuse is defined by your choice of one of the following Creative Commons user licenses:Creative Commons Attribution-NonCommercial-ShareAlike (CC BY-NC-SA): for non-commercial purposes, lets others distribute and copy the article, to create extracts, abstracts and other revised ver
38、sions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text and data mine the article, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, do not modi
39、fy the article in such a way as to damage the authors honor or reputation, and license their new adaptations or creations under identical terms (CC BY-NC-SA).Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, a
40、nd to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article. Elsevier has established agreements with funding bodies, This ensures authors can comply with funding body open access requirements, including specifi
41、c user licenses, such as CC BY. Some authors may also be reimbursed for associated publication fees. If you need to comply with your funding body policy, you can apply for the CC BY license after your manuscript is accepted for publication. To provide open access, this journal has a publication fee
42、which needs to be met by the authors or their research funders for each article published open access.Your publication choice will have no effect on the peer review process or acceptance of submitted articles.The open access publication fee for this journal is US$2500, excluding taxes. Learn more ab
43、out Elseviers pricing policy: Language (usage and editing services)Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors a
44、nd to conform to correct scientific English may wish to use the English Language Editing service available from Elseviers WebShopor visit our customer support sitefor more information. Authors should be aware that papers written in poor English are more likely to be rejected. Authors In Japan please
45、 noteAuthors In Japan please note: if you would like information about how to have the English of your paper checked, corrected and improved (before submission), please contact our Tokyo office who will inform you of the services provided by language correctors: Elsevier, 9-15, Higashi-Azabu 1-chome, Minato-ku, Tokyo 106, Japan.Tel. (+81) 3-5561-5033: Fax (+81) 3-5561-5047; E-mail: infoelsevier.co.jp SubmissionOur online submission system guides you stepwise through the process of entering your article details and uplo
